Evaluation of a Pharmacogenetic-based Warfarin Dosing Algorithm in Patients

NCT02592980 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

300

Enrollment

OTHER

Sponsor class

Conditions

Atrial Fibrillation

Interventions

GENETIC: Pharmacogenetic anticoagulation
DRUG: Traditional anticoagulation

Sponsor

University of Sao Paulo General Hospital

Collaborators

[object Object]
[object Object]
[object Object]